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Abstract
Background: Vital signs are the primary indicator of physiological status and for determining the need for urgent
clinical treatment. Yet, if physiological signs of deterioration are missed, misinterpreted or mismanaged, then critical
illness, unplanned intensive care admissions, cardiac arrest and death may ensue. Although evidence demonstrates
the benefit of early recognition and management of deteriorating patients, failure to escalate care and manage
deteriorating patients remains a relatively frequent occurrence in hospitals.
Methods/design: A pragmatic cluster-randomised controlled trial design will be used to measure clinical effectiveness
and cost of a facilitation intervention to improve nurses’ vital sign measurement, interpretation, treatment and
escalation of care for patients with abnormal vital signs. A cost consequence analysis will evaluate the intervention cost
and effectiveness, and a process evaluation will determine how the implementation of the intervention contributes to
outcomes. We will compare clinical outcomes and costs from standard implementation of clinical practice guidelines
(CPGs) to facilitated implementation of CPGs. The primary outcome will be adherence to the CPGs by nurses, as
measured by escalation of care as per organisational policy. The study will be conducted in four Australian major
metropolitan teaching hospitals. In each hospital, eight to ten wards will be randomly allocated to intervention
and control groups. Control wards will receive standard implementation of CPGs, while intervention wards will
receive standard CPG implementation plus facilitation, using facilitation methods and processes tailored to the
ward context. The intervention will be administered to all nursing staff at the ward level for 6 months. At each
hospital, two types of facilitators will be provided: a hospital-level facilitator as the lead; and two ward-level
facilitators for each ward.
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Discussion: This study uses an innovative, networked approach to facilitation to enable uptake of CPGs. Findings
will inform the intervention utility and knowledge translation measurement approaches. If successful, the study
methodology and intervention has potential for translation to other health care standards.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12616000544471p
Keywords: Implementation, Facilitation, Knowledge translation, Clinical decision-making, Patient safety,
Guidelines, Vital signs, Randomised controlled trial, Process evaluation, Economic analysis
Background
Contemporary hospitals treat increasingly complex pa-
tients suffering from multiple health care problems [1].
Although there are many tools available to assess pa-
tients’ responses to illness and treatment, vital signs
(VS) are the primary indicator of physiological status
and the most common assessment technique employed
in health care. If physiological signs of deterioration are
missed, misinterpreted or mismanaged, then serious ad-
verse events (SAEs) such as critical illness, cardiac arrest,
unplanned intensive care admissions and death may re-
sult. Identification of abnormal VS can assist in the de-
tection of at-risk patients minutes to hours before the
occurrence of SAEs [2]. VS measurement and escalation
of care is fundamental to patient safety and the first step
in patient rescue.
International evidence highlights the severity of ad-
verse outcomes when VS are not recognised as abnormal
or responded to appropriately [3, 4]. An Australian study
found that the presence of three or more abnormal VS
was associated with a 19-fold increase in mortality risk
as compared to patients with a single abnormal VS [5].
Since 1995, Australia has led the way in system redesign,
countering the morbidity and mortality associated with
failure to rescue. One strategy, rapid response systems
(RRS) and in particular medical emergency teams (MET)
takes critical care expertise to the wards when predeter-
mined activation criteria (VS and other measurements)
are met. The success of MET and impact on patient out-
comes depends on activation actually occurring when in-
dicated. However, we have shown that this does not
always occur with 3–53% of patients meeting criteria for
activation actually receiving a RRS call [6–8]. Failure to
call the RRS for patients fulfilling activation criteria oc-
curs despite the release of international guidelines [9,
10] and the prioritisation of Standard 9 (recognition and
response to clinical deterioration in acute health care) as
one of the ten National Quality and Safety Health Ser-
vice (NQSHS) Standards required for Australian hospital
accreditation from 2011 [11]. A significant gap between
current evidence and practice exists.
In our survey of 1688 patients in 10 acute care hospi-
tals, the prevalence of patients fulfilling MET criteria in
the 24 h prior to data collection was 5.3% and on the
day of observation was 3.3% [7]. Of the 55 patients who
fulfilled the MET criteria, only 2 (3.6%) had a MET call
activated within 24 h. Patients who fulfilled MET criteria
at the time of vital sign acquisition were more likely to
die in hospital (RR = 2.95; 95% confidence interval (CI)
1.22 to 7.15) or within 30 days (RR = 2.64; 95% CI 1.37
to 5.11). Our research has also shown the incidence of
patients fulfilling MET calling criteria to be 14.4% during
their hospital admission, and of those patients, only 2.9%
received a MET call. Further, patients who fulfilled MET
activation criteria had double the hospital length of stay
[8]. Thus, timely and effective intervention is critical.
Although a growing body of international evidence
demonstrates the benefit of early recognition and
management of deteriorating patients, suboptimal man-
agement has serious consequences and represents a
research-practice gap [12]. One recent study further
highlighted this gap in a sample of 422 patients; escal-
ation was indicated on 109 occasions, yet contrary to
hospital policy, only 58 (53%) were escalated appropri-
ately [6]. This failure to escalate and manage patients
concurs with our previous research [7] and others inter-
nationally [3, 4, 13]. There is a need to understand the
causes, mechanisms and strategies to overcome the
problem using knowledge translation (KT) frameworks.
One widely researched and used KT framework is the
Promoting Action on Research Implementation in Health
Services (PARIHS) Framework [14–16], which views imple-
mentation as a dynamic and multi-faceted process. The
proposition is that successful implementation is a function
of the nature and type of evidence, the qualities of the con-
text in which the evidence is being introduced, and the way
the process is facilitated [15]. Although many strategies are
thought to be effective in promoting individual and organ-
isational change, the change agent role is believed to be a
key ingredient for KT. Additionally, systematic reviews
have found educational outreach of practice facilitation in
health care have improved patient care [17, 18].
Methods/design
This knowledge translation study uses a pragmatic
cluster-randomised controlled trial (C-RCT) design, with
process evaluation and cost consequence analysis, to
measure the clinical effectiveness and costs of a
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facilitation intervention to improve nurses’ VS measure-
ment, interpretation, treatment and escalation of pa-
tients with abnormal VS. We will compare outcomes
and costs from standard implementation of clinical prac-
tice guidelines (CPGs) to facilitated implementation of
CPGs. An embedded process evaluation will assist in
obtaining a deeper understanding of the variable con-
texts of implementation, the barriers and enablers
encountered, the response by stakeholders and the re-
sources required for implementation.
This project aims the following:
1. To improve nurses’ adherence to clinical practice
guidelines (CPG) for identifying and managing
deteriorating patients in hospital
2. To determine the clinical effectiveness and costs of a
Facilitation Intervention for Practice improvement
(FLIP) to improve nurses’ adherence to the CPGs
3. To assess the impact of contextual characteristics on
processes and outcomes of implementation
4. To develop and disseminate recommendations to
health policy and practice decision makers
Primary hypothesis
Nurses in wards receiving standard CPG implementation
plus a facilitation intervention (FLIP) will demonstrate
greater adherence to CPGs for identifying and managing
deteriorating patients compared to nurses in wards re-
ceiving standard CPG dissemination alone.
Secondary hypotheses
Nursing practice outcomes: Patients in wards receiving
the FLIP will have increased documented VS (complete
sets), repeated VS within 30 min of obtaining an abnormal
VS, documented nursing scope of practice interventions
in response to abnormal vital signs, increased activations
for urgent clinical reviews and METcalls in patients fulfill-
ing the criteria. Clinical Outcomes: Patients in wards re-
ceiving the FLIP will have fewer cardio-respiratory arrests,
less unplanned intensive care unit (ICU) admissions,
lower unexpected hospital mortality rates and reduced
hospital length of stay (HLOS). Health Economic Out-
come: The cost of implementing the FLIP will be offset by
savings from shorter HLOS and reduced ICU admissions.
FLIP will represent a cost-effective use of resources.
The study is designed to adhere to the Good Clinical
Practice (GCP) Guidelines for national ethics standards
and is consistent with the C-RCT CONSORT statement
[19] and the CHEERS statement [20], ensuring it meets
international ethical and scientific quality standards for
reporting clinical trials that include an economic evalu-
ation (see Fig. 1).
Fig. 1 Consort diagram. This figure provides the flow diagram of the phases of the cluster-randomised controlled trial
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Outcome measures
Primary outcome
The primary outcome is the adherence to the CPGs for
recognition and management of clinical deterioration by
nurses, as measured by the escalation of care as per hos-
pital policy.
Secondary outcomes
The secondary outcomes are as follows: Nursing prac-
tice: Nurses’ adherence to CPGs measured by propor-
tions of documented VS (complete set), repeated VS
within 30 min of obtaining an abnormal VS and docu-
mented nursing scope of practice interventions in re-
sponse to abnormal vital signs; proportions of activated
urgent clinical reviews and MET calls in patients fulfill-
ing the criteria. Clinical: Rates of cardio-respiratory ar-
rests, unplanned admissions to ICU, unexpected hospital
mortality and mean HLOS. Costs: Mean additional cost
of implementing the intervention and mean/median
total hospital cost and HLOS for patients. Process evalu-
ation: measurement of the fidelity of the facilitation
intervention, contextual influences and impact on ward
processes and practice.
Setting
Four hospitals in Victoria, Australia, will be the setting
for this study. All are acute, major metropolitan teaching
hospitals that have more than 400 beds, employ over
1300 nurses and cover both acute and specialist services.
Sponsorship for the study was sought from the Executive
Directors of Nursing and Chief Executive Officers of
each hospital prior to the funding application. Within
each hospital, eight to ten wards will be randomly allo-
cated to either intervention or control groups; the inter-
vention will be delivered at ward level. Each ward is
considered a cluster for the purpose of analysis. Wards
will be eligible for inclusion if they contain 18 or more
beds and they receive support from the hospital’s MET.
Critical care, emergency, paediatrics, maternity, peri-
operative and psychiatric areas will be excluded because
they use an alternative response system for patient
deterioration.
Sample/participants
All staff working within study wards and whose role is
direct care delivery will be involved in the study. Each
ward has a permanent staff, reducing the likelihood of
contamination from staff movement. Nurse managers
(NM) will recruit staff to participate in focus groups or
individual interviews for the process evaluation; the RA
will obtain consent. Medical records of patients from
participating wards will be audited over three randomly
selected 24-h periods during 1 week at three time points
(baseline, immediately post-intervention and 6 months
post-intervention) to identify all ward patients in a 24-h
period who have abnormal VS. These cohorts of patients
will be followed up for the duration of their hospital stay
and analysed according to ward (intervention or con-
trol), irrespective of subsequent ward transfers that may
occur using the principles of intention-to-treat (ITT)
analysis.
Sample size
From a medical record review in one of the sites, the
rate of adherence to escalation policy after abnormal VS
measurement was 53% [6]. Sample size calculations are
based on a 50% rate of adherence to escalation as per
hospital policy. To detect a 20% improvement in adher-
ence rate in the intervention group immediately follow-
ing and 6 months post-intervention, 270 documented
abnormal VSs per time point per study arm are required.
Our sample size has been inflated to allow for a design
effect of 1.5, accounting for within-patient autocorrel-
ation and within ward clustering effect. Type I error is
set at a 1% significance level accounting for multiple
comparisons and study power is set to 90%. For second-
ary outcomes, we have 80% power to detect an odds ra-
tio of at least 1.8 in post-intervention comparisons for
an improved adherence rate in the intervention com-
pared to the control group. For all other secondary
outcomes, power calculations have been based on com-
bining immediately following intervention and 6 months
post-intervention data. For the unplanned ICU admis-
sion rate, a minimum of 0.3% difference (1.2 vs 0.9%);
for MET call rate a minimum of 2.3% absolute difference
(3 vs 0.7%); and at least 1.6 day (IQR = 20) median abso-
lute difference (12 vs 10.4) for hospital LOS is detectable
at 80% power. Due to a low incidence of cardio-
respiratory arrests and hospital mortality, a power ana-
lysis is based on combining mortality and code blue,
resulting in 80% power to detect a minimum 2.3% abso-
lute difference (3 vs 0.7%).
Randomisation
Random 1:1 block randomisation of wards within hospi-
tals to intervention or control groups will be undertaken.
A central randomisation service independent of the
study will be used with concealment until the interven-
tion is assigned. Assessment days will be randomly
selected.
Control group
The control group ward staff will receive the standard
implementation of CPGs. This will include information
on the CPG, its availability online, as well as notification
of the free online educational courses available to in-
crease their knowledge and understanding about the
identification and management of deteriorating patients.
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Information will be provided to each NM for dissemin-
ation to ward staff.
Intervention group
The intervention group ward staff will receive the stand-
ard implementation of CPGs as described above plus the
facilitation intervention for practice improvement
(FLIP). FLIP comprises individuals in facilitator roles
using facilitation methods and processes in a flexible
way to tailor implementation strategies to the local ward
context, according to identified barriers and enablers.
There will be two types of internal facilitator roles:
hospital facilitators (HFLIP) and ward facilitators
(WFLIP). A hospital facilitator will be appointed to cover
four or five intervention wards in each of the four hospi-
tals, acting as the overall facilitation lead and coordin-
ator and mentor for the ward facilitators in each
hospital. In each intervention ward, two ward facilitators
will be appointed to support and enable ward nurses to
implement the CPGs into practice (N = 36). Each HFLIP
will be prepared and supported by an external expert in
facilitation (GH). Each HFLIP will work with eight to
ten WFLIPs. The facilitation intervention is underpinned
by the PARIHS [14, 16] and i-PARIHS [21] frameworks.
Training and a toolkit of methods and techniques will
be given to all FLIPs to promote the transfer of CPGs
into daily practice. The intervention wards will receive
5 h per week support from the HFLIP for 6 months,
reviewing barriers and enablers to implementing CPGs
into practice prior to intervention commencement and
in discussion with the WFLIPs. The HFLIP will provide
face to face interactive education, including small group
work, case presentations and role play, as well as review
ward specific systems, processes, routines and audit
practices in order to align systems of care to enable im-
plementation of CPGs into daily practice. At ward level,
the two WFLIPs will work with the HFLIP to audit prac-
tice, identify barriers, strategies and goals for improve-
ment. They will provide cover for each other during
leave and support ward staff during practice hours, re-
ceiving one day per fortnight of protected time for con-
ducting audits, facilitation of ward nurses and meeting
with the HFLIP to agree on strategies to improve adher-
ence to guidelines.
Recruitment and selection of facilitators
HFLIP positions will be advertised on the hospitals’
intranet and through a snowballing technique, to iden-
tify interested staff. Local staff will be interviewed and
selected to build capacity within the participating orga-
nisations at a clinical leadership level. HFLIPs should
have some prior experience (e.g. in practice development
or an education role) so that they can support and men-
tor the WFLIPS and deal with the more challenging
contextual barriers that may arise. Selection of all FLIPs
will be based on the following characteristics: knowledge
of and interest in NSQHC Standard 9; knowledge of col-
leagues, ward, and organisation; holds a clinical leader-
ship role; and possesses good communication skills.
Nurse managers will be asked to identify two WFLIPs
for their wards based on the above criteria. All potential
WFLIPs will be asked to consent to participation.
Training and intervention fidelity
Research assistants (RAs) and facilitators will undergo
onsite training to ensure consistency across all sites.
Training will be tailored to the type of RA (outcome,
process or economic assessor) or facilitation role
(WFLIP or HFLIP) and be focused on consistency/fidel-
ity. Standardised procedure manuals will be provided to
all RAs and facilitators with specific detail on roles and
responsibilities.
HFLIPs will receive training for 3 days from two ex-
perts in recognition and response to deterioration and
advanced facilitation skills. HFLIPs will receive mentor-
ing and ongoing support throughout the trial in a
monthly teleconference with an external facilitator and
Project Manager, as well as opportunities to teleconfer-
ence at any time should questions or issues arise. One
face to face HFLIP meeting and site visit will be con-
ducted during the intervention. HFLIPs will receive
contact details for other HFLIPs to encourage communi-
cation across sites, share learnings and troubleshoot bar-
riers to facilitation. Ward FLIPs will receive training for
a single day including knowledge on recognition and re-
sponse to deterioration, beginner facilitation skills, and
will receive mentoring and ongoing support during the
trial. Support for WFLIPs will be provided by HFLIPs
during the trial in the time allocated to each ward and
via phone or email at other times. All interactions with
WFLIPs will be captured by HFLIPs using electronic ac-
tivity logs. Education modules, developed and used pre-
viously in research will be employed, including the
following: using evidence in professional practice,
implementing guidelines into practice, identifying and
managing deteriorating patients, and facilitating and
auditing. The intensity of the intervention will be moni-
tored across sites. All HFLIP activities will be recorded
on electronic activity and communication logs. HFLIPs
will also audit ward practice 1 week each month for the
duration of the intervention period. Audits will include
half the occupied beds in each ward (every second bed).
Audit data will be collected electronically and then for-
matted into feedback graphs and text. Text will contain
a main message arising from the data. Feedback will be
delivered to each WFLIP for discussion at ward meetings
or individually to ward staff. WFLIPS will be taught the
audit process to assist with their understanding of ward
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practices in relation to recognition and management of
patient deterioration and for practice sustainability at
the completion of the trial.
Research assistants performing data extraction from
medical records will be given training on the electronic
data collection tool and accompanying data dictionary.
Inter-rater reliability testing will be established by inde-
pendent double auditing across sites until Kappa >0.95
is achieved, with a minimum of 10 medical records
audited per research assistant. In addition, a study moni-
toring audit will be conducted by the project manager
on a random sample of 100 patient charts across four
sites to ensure continued accuracy of data extraction by
research assistants.
Blinding
All RAs will be blinded to group allocation. Success of
blinding will be assessed at study end using the James
Blinding Index [22]. Although facilitators will not be
blinded and nurses will be aware of the FLIP, ward
nurses will be unaware of the comparator. Patients will
be unaware of the intervention. MM, JW and the RAs
will analyse the data, and all will be blinded to group
allocation.
Instruments
The electronic Case Report Form (eCRF) was adapted
from our previous research [6, 7] to collect data relating
to (1) documented vital signs (respiratory rate, heart
rate, temperature, blood pressure, conscious state and
oxygen saturation), CRC and MET activations; (2) pa-
tient outcomes, including unplanned ICU admissions,
cardio-respiratory arrests, limitations of medical treat-
ment orders, LOS and inpatient mortality; and (3) nurs-
ing interventions and referrals in response to abnormal
vital signs and escalation as per hospital policy.
Electronic Activity and Communication Log (eACL)
data will be collected at the time of activity and through-
out the duration of the intervention. Data captured will
include methods and techniques outlined in the Facilita-
tor Manuals, enablers and barriers, and measures of
impact.
Assessments
Aims 1 and 2
Outcome data collection will occur across three time
points: at baseline prior to implementation, immediately
following completion of the intervention (6 months) and
6 months post-intervention (12 months). At each time
point, the medical records of all inpatients admitted to
study wards will be reviewed by a RA (blinded to group
allocation) to determine if abnormal VS were present,
and if so, the rates of escalation as per hospital policy,
HLOS, unplanned ICU admissions and unexpected
inpatient mortality. Data collection days will be ran-
domly selected. RAs will be trained in data entry. Prior
to RAs collecting data independently, inter-rater reliabil-
ity will be evaluated by the project manager who is a
registered nurse with specialist intensive care qualifica-
tions. Independent data extraction will be conducted
until >95% agreement is obtained. The secure data entry
system will not allow invalid values; data backup mea-
sures will be installed. Costs attributed to FLIP and
training will be calculated.
Aim 3
Facilitators will complete electronic activity logs; ward
communication and policy changes will be collected by
RAs electronically. To capture the experience of FLIPs
and key stakeholders regarding the intervention and
CPG implementation, semi-structured individual and
focus group interviews and field observations will be
conducted at critical points in the project—before, dur-
ing and after the intervention. Interviews will be audio-
recorded and transcribed verbatim.
All assessments are outlined in Table 1.
Data analysis
Quantitative methods will be used to analyse patient,
health services utilization and economic outcomes. Main
and secondary outcome analysis will be based on all ran-
domised wards and selected participants (intention-to-
treat analysis). To account for within-patient correlation,
due to multiple measurements from the same patient
during assessment days, we will implement generalized
estimating equation (GEE) models with binary outcome
and logit link for all rate outcome comparisons [23]. The
Cochran-Mantel-Haenszel (CMH) test will be used to
compare proportions. Clustering effects for wards will
be evaluated by calculating intraclass correlation coeffi-
cients and, if necessary, a fixed effect nominal factor will
be included in GEEs to account for ward impact. A
series of exploratory analyses will be conducted on sub-
groups and the impact of covariates on estimates of the
effect of the intervention. A nonparametric median test
will be used for HLOS comparison. In supportive ana-
lysis, HLOS will be considered as time to event data.
Survival rates will be calculated and illustrated by the
Kaplan–Meier method and further analysed by the log-
rank test for univariate analysis (stratified by wards).
Variables that reveal prognostic or effect modifying po-
tential on the outcome as suggested by univariate ana-
lysis will subsequently be evaluated by the proportional
Cox regression for multivariate analysis. Hazard ratios
with the corresponding 95% confidence intervals will be
reported. A p value of <0.05 is considered statistically
significant. Data will be analysed using Stata version 14
or later [24].
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Cost analysis
Analysis of the costs of hospitalisation will be deter-
mined at the patient level over the 6-month period for
intervention and control wards. All patients admitted to
the study wards during the 6-month study period will be
included in the analysis of mean total cost, HLOS and
ICU LOS for intervention and control wards in each
hospital. Only complete admissions will be included (pa-
tients admitted to a study ward and discharged from the
hospital within the study period); and patients will be
analysed based on their admission ward. Mean costs and
HLOS for each patient in each ward will be compared to
costs and HLOS for patients admitted to the same wards
in the 6 months prior to the study period. Difference in
difference analyses will be undertaken to compare the
mean cost and HLOS difference between pre-intervention
and intervention periods, and between intervention and
control wards across hospitals. Costs will be attributed to
the FLIP intervention based on the additional costs of the
implementation process (staff time) over standard in-
hospital CPG training.
Process evaluation
In order to determine how the implementation of the
intervention contributes to the observed outcomes, data
will be collected in four domains: intervention imple-
mentation, the recipients of the intervention perceptions
and views of the evidence and implementation, re-
sponses of the staff implementing (or supporting imple-
mentation) of the CPG recommendations and the
contextual influences mediating implementation. Inter-
views, field observations and focus group transcripts will
be subject to thematic analysis [25]. Analysis will be
iterative, refining emerging themes, then comparing
themes and relationships through a process of pattern
matching to examine for data consistency. Themes and
relationships will be re-examined and recoded by two
members of the research team. Analysis will continue
until no new themes emerge and agreement on themes
is achieved.
Develop and disseminate recommendations with health
policy and practice decision makers
Aim 4
An expert advisory group (EAG) consisting of Chief in-
vestigators, Associate Investigators and Partner Organ-
isation representatives with expertise in nursing,
medicine, NSQHS Standard 9, KT and policy making
will develop recommendations that bring together key
elements, strategies, tools and resources identified to im-
prove patient safety and provide recommendations for
system-wide health service improvements.
We will use a multi-faceted approach to translate and
disseminate the findings of this study to health profes-
sionals, administrators and policy-makers. The study
methodology and findings will be of particular interest
and relevance to health professionals and administrators.
The findings will also be of interest to those wanting to
better understand how to translate evidence into practice
through facilitation. We will use traditional approaches to
knowledge dissemination through high-quality publica-
tions in peer-reviewed journals and presentations at major
international and national conferences, as well as through
our formal and informal networks, nationally and inter-
nationally. All members of the expert advisory group have
active collaborations with other health care organisations
Table 1 Data collection
Aim Variable/Measure Instrument Outcomes Data collection point
1 Adherence to
CPG
eCRF CPG element compliance: completed VS
documentation; repeated VS within 30 min;
interventions within scope of practice; CRC and
MET activations; escalation as per hospital policy.
Baselinea, 6 and
12 monthsb
2 Patient outcomes eCRF; Hospital clinical databases Unplanned ICU admissions, cardio-respiratory
arrests, limitations of medical treatment orders,
HLOS and inpatient mortality.
Baselinea, 6 and
12 monthsb
2 Hospital costs CRF; Hospital clinical costing databases. Unplanned ICU admissions, HLOS and inpatient
mortality; total cost of hospital episode.
Hospital episodeb
2 Intervention
costs
CRF; Staffing salaries FLIP cost; training frequency Continuous
3 FLIP dose eACL Contact and content of contact. Continuous
3 Enablers/barriers eACL/ Ward Communication Books, RISKMAN
incidents, Focus groups.
Issues arising; Critical incident analysis. Continuous
3 Ward Impact Ward Communication Books, policies and
procedures, interviews, field observations.
Frequency and content. Continuous
3 Facilitator Impact Interviews with all FLIPS Perceptions and content. 6 monthsb
aPrior to commencement of intervention (baseline)
bOn completion of intervention (6 and 12 months post-baseline data collection)
Bucknall et al. Implementation Science  (2017) 12:85 Page 7 of 9
and National Advisory Committees. Forums and presenta-
tions will be held at participating hospitals which are com-
mitted to knowledge sharing in order to promote safe,
high-quality care delivery.
Trial status
This study has received ethics approval and data collec-
tion is currently underway.
Discussion
Individual patients vary in their responses to treatment,
and their health status can change rapidly with little
warning. Critical illness, cardiac arrest, unplanned inten-
sive care admissions and death may result if physio-
logical signs of deterioration are missed, misinterpreted
or mismanaged. These serious events occur multiple
times daily in hospitals and frequently result from
communication failures during changes in a patient’s
clinical status. The consequences for the patient can
be catastrophic and the costs to the community are
significant [13].
Despite the existence of international guidelines that
recommend early recognition and response to deterior-
ation [10, 11, 26], a research-practice gap remains.
Much of the focus has been on disseminating decision
support tools in organisations rather than enabling
change in clinician behaviour. These factors along with
calls for more theory-informed interventions, using ro-
bust and methodologically sound research [27], have
prompted the development of this facilitation interven-
tion. The study design focuses on testing the effective-
ness of a facilitation intervention to implement clinical
practice guidelines on the recognition of and response
to clinical deterioration by ward nurses. This study
evaluates a networked approach to facilitation, creating
an organizational infrastructure and building capacity
in the skills and knowledge required for translating evi-
dence into clinical practice. Facilitators use facilitation
skills and knowledge to help individuals, teams and or-
ganisations apply evidence into practice [15]. This
research will investigate the relationship between facili-
tation and the impact on evidence use and patient out-
comes, as well as contextual factors that influence
implementation processes.
This study uses an innovative and novel approach to
deliver a networked approach to facilitation to enable
knowledge translation. It will inform knowledge transla-
tion measurement approaches using process evaluation
and health economic techniques. If successful, the facili-
tation methodology has the potential for translation to
other health care standards such as medication safety,
falls and pressure injury prevention; all high-risk areas
for health services and important issues for patients and
their families.
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